These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

589 related articles for article (PubMed ID: 20624444)

  • 1. Adolescent brain maturation, the endogenous cannabinoid system and the neurobiology of cannabis-induced schizophrenia.
    Bossong MG; Niesink RJ
    Prog Neurobiol; 2010 Nov; 92(3):370-85. PubMed ID: 20624444
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cannabis and psychiatric disorders: it is not only addiction.
    Leweke FM; Koethe D
    Addict Biol; 2008 Jun; 13(2):264-75. PubMed ID: 18482435
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cannabis, cannabinoids and schizophrenia: integration of the evidence.
    Cohen M; Solowij N; Carr V
    Aust N Z J Psychiatry; 2008 May; 42(5):357-68. PubMed ID: 18473254
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Puberty as a highly vulnerable developmental period for the consequences of cannabis exposure.
    Schneider M
    Addict Biol; 2008 Jun; 13(2):253-63. PubMed ID: 18482434
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cannabis and the developing brain: insights from behavior.
    Trezza V; Cuomo V; Vanderschuren LJ
    Eur J Pharmacol; 2008 May; 585(2-3):441-52. PubMed ID: 18413273
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Neurophysiology of cannabis].
    Spadone C
    Encephale; 1991; 17(1):17-22. PubMed ID: 1688273
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cannabinoids and psychosis.
    D'Souza DC
    Int Rev Neurobiol; 2007; 78():289-326. PubMed ID: 17349865
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adverse effects of cannabis.
    Prescrire Int; 2011 Jan; 20(112):18-23. PubMed ID: 21462790
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Cannabis and Schizophrenia: new findings in an old debate].
    Kawohl W; Rössler W
    Neuropsychiatr; 2008; 22(4):223-9. PubMed ID: 19080993
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long lasting consequences of cannabis exposure in adolescence.
    Rubino T; Parolaro D
    Mol Cell Endocrinol; 2008 Apr; 286(1-2 Suppl 1):S108-13. PubMed ID: 18358595
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Glutamate and schizophrenia: phencyclidine, N-methyl-D-aspartate receptors, and dopamine-glutamate interactions.
    Javitt DC
    Int Rev Neurobiol; 2007; 78():69-108. PubMed ID: 17349858
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cannabinoids and psychosis.
    Sewell RA; Ranganathan M; D'Souza DC
    Int Rev Psychiatry; 2009 Apr; 21(2):152-62. PubMed ID: 19367509
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cannabis use and the risk of later schizophrenia: a review.
    Smit F; Bolier L; Cuijpers P
    Addiction; 2004 Apr; 99(4):425-30. PubMed ID: 15049742
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cannabis and psychosis: an update on course and biological plausible mechanisms.
    Linszen D; van Amelsvoort T
    Curr Opin Psychiatry; 2007 Mar; 20(2):116-20. PubMed ID: 17278907
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Familial predisposition for psychiatric disorder: comparison of subjects treated for cannabis-induced psychosis and schizophrenia.
    Arendt M; Mortensen PB; Rosenberg R; Pedersen CB; Waltoft BL
    Arch Gen Psychiatry; 2008 Nov; 65(11):1269-74. PubMed ID: 18981338
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The pharmacology of the endocannabinoid system: functional and structural interactions with other neurotransmitter systems and their repercussions in behavioral addiction.
    López-Moreno JA; González-Cuevas G; Moreno G; Navarro M
    Addict Biol; 2008 Jun; 13(2):160-87. PubMed ID: 18422831
    [TBL] [Abstract][Full Text] [Related]  

  • 17. What Can Rats Tell Us about Adolescent Cannabis Exposure? Insights from Preclinical Research.
    Renard J; Rushlow WJ; Laviolette SR
    Can J Psychiatry; 2016 Jun; 61(6):328-34. PubMed ID: 27254841
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adolescent exposure to cannabis as a risk factor for psychiatric disorders.
    Rubino T; Zamberletti E; Parolaro D
    J Psychopharmacol; 2012 Jan; 26(1):177-88. PubMed ID: 21768160
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The activation of cannabinoid receptors during early postnatal development reduces the expression of cell adhesion molecule L1 in the rat brain.
    Gómez M; Hernández M; Fernández-Ruiz J
    Brain Res; 2007 May; 1145():48-55. PubMed ID: 17320842
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Glutaminergic hypothesis of schizophrenia: clinical research studies with ketamine].
    Mechri A; Saoud M; Khiari G; d'Amato T; Dalery J; Gaha L
    Encephale; 2001; 27(1):53-9. PubMed ID: 11294039
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 30.